This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Find out more about how we use cookies and how to manage them by reading our cookie notice.

Paul Jansson / Naimish Patel

Project Leader, AZD7624 / MD, Medical Science Director in Early Clinical Development, Respiratory, Inflammation, and Autoimmunity Translational Medicines Unit

Paul Jansson
As a project leader within the respiratory inflammation and autoimmunity innovative medicines unit, I focus my effort on finding the best development path forward.

Naimish Patel
Dr. Patel is a board certified physician in Pulmonary and Critical Care Medicine. He currently works as a Medical Science Director in Early Clinical Development in the Respiratory, Inflammation, and Autoimmunity Translational Medicines Unit at AstraZeneca. Dr. Patel has a background in translational and clinical research with a focus on lung immunity and infections. He trained at the Harvard Combined Program in Pulmonary and Critical Medicine, and still holds a part-time faculty position at Harvard Medical School and Beth Israel Deaconess Hospital. Dr. Patel also continues to practice Pulmonary Medicine at Beth Israel Deaconess Hospital in Boston.

You are viewing: All posts Reset filters

Our Other Authors